Heimann Andrea S, Gupta Achla, Gomes Ivone, Rayees Rahman, Schlessinger Avner, Ferro Emer S, Unterwald Ellen M, Devi Lakshmi A
Proteimax Biotechnology LTDA, Av Corifeu de Azevedo Marques, São Paulo, SP, Brazil.
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America.
PLoS One. 2017 Nov 1;12(11):e0187306. doi: 10.1371/journal.pone.0187306. eCollection 2017.
The N-terminal region of G protein-coupled receptors can be efficiently targeted for the generation of receptor-selective antibodies. These antibodies are useful for the biochemical characterization of the receptors. In this study, we developed a set of criteria to select the optimal epitope and applied them to generate antibodies to the N-terminal region of 34 different G protein-coupled receptors. The antibody characterization revealed that a subset of antibodies exhibited increased recognition of the receptor following agonist treatment and this increase could be blocked by treatment with the receptor antagonist. An analysis of the epitopes showed that those antibodies that exhibit increased recognition are on average twelve residues long, have an overall net negative charge and are enriched in aspartic and glutamic acids. These antibodies are useful since they facilitate studies examining dose dependent increases in recognition of receptors in heterologous cells as well as in native tissue. Another interesting use of these antibodies is that they facilitate measuring changes in receptor recognition in brain following peripheral drug administration; for example, systemic administration of cocaine, a blocker of dopamine transporter that increases local dopamine levels at the synapse, was found to lead to increases in antibody recognition of dopamine receptors in the brain. Taken together these studies, in addition to describing novel tools to study native receptors, provide a framework for the generation of antibodies to G protein-coupled receptors that can detect ligand-induced conformational changes.
G蛋白偶联受体的N端区域可被有效地用于生成受体选择性抗体。这些抗体对于受体的生化特性研究很有用。在本研究中,我们制定了一套标准来选择最佳表位,并将其应用于生成针对34种不同G蛋白偶联受体N端区域的抗体。抗体特性分析表明,一部分抗体在激动剂处理后对受体的识别增加,且这种增加可被受体拮抗剂处理所阻断。表位分析显示,那些识别增加的抗体平均长度为12个残基,总体带净负电荷,且富含天冬氨酸和谷氨酸。这些抗体很有用,因为它们有助于研究异源细胞以及天然组织中受体识别的剂量依赖性增加。这些抗体的另一个有趣用途是,它们有助于测量外周给药后大脑中受体识别的变化;例如,发现全身给予可卡因(一种多巴胺转运体阻滞剂,可增加突触处局部多巴胺水平)会导致大脑中多巴胺受体的抗体识别增加。综合这些研究,除了描述研究天然受体的新工具外,还为生成能够检测配体诱导构象变化的G蛋白偶联受体抗体提供了一个框架。